What is FAY?
FAYnutrition operates at the critical intersection of health-tech and preventative medicine. By providing a robust platform for telehealth and face-to-face counseling, the company addresses the growing demand for accessible, high-quality nutrition services. FAY distinguishes itself by integrating technology with human-centric care, ensuring that patients receive tailored guidance regardless of their geographic location. As the digital health landscape matures, FAY's hybrid model serves as a vital bridge between traditional clinical nutrition and modern, on-demand healthcare delivery, effectively capturing market share in the wellness and chronic disease management verticals.
How much funding has FAY raised?
FAY has raised a total of $75M across 3 funding rounds:
Angel/Seed
$5M
Series A
$20M
Series B
$50M
Series A (2024): $20M with participation from Forerunner Ventures and General Catalyst
Angel/Seed (2024): $5M led by General Catalyst
Series B (2025): $50M supported by Goldman Sachs Group, Forerunner Ventures, and General Catalyst
Key Investors in FAY
General Catalyst
A prominent venture capital firm that identifies and supports transformational business opportunities across multiple sectors, including healthcare and enterprise software.
Forerunner Ventures
A VC firm specializing in early-stage and growth-stage companies that sit at the intersection of technology and human behavior, with a strong focus on wellness and consumer health.
Goldman Sachs Group
A leading global investment banking and management firm that provides strategic advisory and capital market expertise to support the scaling of high-impact enterprises.
What's next for FAY?
With the successful closure of its latest financing round, FAY is entering a pivotal phase of enterprise-level scaling. The company is expected to utilize this capital to enhance its proprietary telehealth infrastructure, expand its network of nutrition professionals, and deepen its market penetration across the United States. Given the involvement of top-tier institutional investors, FAY is well-positioned to navigate the complexities of the healthcare regulatory environment while maintaining its trajectory of rapid growth. Future strategic initiatives will likely focus on optimizing patient outcomes through data-driven insights and forging deeper partnerships within the broader healthcare ecosystem to solidify its status as a category-defining entity in the nutrition technology space.
See full FAY company page
